Describing the Patient Journey of Women with Claims for Uterine Fibroids and Heavy Menstrual Bleeding Using a Commercial Database (2011–2020)
Sanjay K Agarwal,1 Michael Stokes,2 Tiffany Kung,3 Rong Tilney,2 Cassandra Lickert3 1UC San Diego, La Jolla, CA, USA; 2Evidera, St. Laurent, Quebec, Canada; 3Myovant Sciences, Inc (now known as Sumitomo Pharma America, Inc), Marlborough, MA, USACorrespondence: Cassandra Lickert, Sumitomo Pharma Amer...
Saved in:
Main Authors: | Agarwal SK (Author), Stokes M (Author), Kung T (Author), Tilney R (Author), Lickert C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uterine fibroids with heavy menstrual bleeding stratified by race in a commercial and Medicaid databaseAJOG Global Reports at a Glance
by: Sanjay K. Agarwal, MD, FACOG, et al.
Published: (2024) -
GnRH analogs for the treatment of heavy menstrual bleeding associated with uterine fibroids
by: Obianuju Sandra Madueke-Laveaux, M.D., M.PH, et al.
Published: (2023) -
Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
by: Juliawati Muhammad, et al.
Published: (2022) -
Medical treatment for heavy menstrual bleeding
by: Yi-Jen Chen, et al.
Published: (2015) -
Abnormal uterine bleeding in adolescence - three cases of heavy menstrual bleeding (HMB)
by: Dominika Zajdel, et al.
Published: (2022)